<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170301032837N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-05-11</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>The effect of ultrasound guided intercostobrachial nerve block on tourniquet pain in axillary block</public_title>
      <acronym></acronym>
      <scientific_title>The effect of ultrasound guided intercostobrachial nerve block on tourniquet pain in patients undergoing axillary block in soft arm and forearm surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/45049</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: Simple, individual randomization using random number table, so that the first patient was drawn by drawing lots in one of the three groups and the next patient was placed in one of the other two groups by using the table of random numbers based on even and odd numbers. And this sequence continued. Only the blocking researcher knew the random sequence, Blinding description: The participants in this study have no knowledge of the nerve block method and in which research group they belonged. The block was performed by the researcher and the evaluating researcher was not present in the room at the time of the block and another evaluates the outcomes without knowing which group the participant belongs to.Due to the fact that the intercostobrachial nerve block is performed during the axillary block, there is no apparent difference between patients after it is performed.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Tourniquet pain in axillary block.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: ultrasound guided intercostobrachial nerve block group. In this group, after IV access and monitoring of vital signs, patients undergoing sedation with Midazolam 0.15 mg/kg and fentanyl 1.5 micrograms/kg and then is placed in a supine position with his upper extrimity 90 degree angle with the body.The axillary area and the medial part of the arm are then prepared with betadine solution and draped. Using sonography (S- Nerve Ultrasound, Sonosite, Inc. WA, USA) and nerve stimulator (Plexygon, VYGON, Inc. Italy) and needle number 21 (Locoplex, VYGON, France), at first four nerves of the median, ulna, radial, and musculoskeletal nerves are blocked, each with 7 cc of lidocaine 1.5 percent, and then the intercostobrachial nerve above the deep fascia are blocked with ultrasound and 2 cc of 1.5% lidocaine. Intervention 2: Intervention group 2: intercostobrachial nerve block without ultrasound group. In this group, after IV access and monitoring of vital signs, patients undergoing sedation with Midazolam 0.15 mg/kg and fentanyl 1.5 micrograms/kg and then is placed in a supine position with his upper extrimity 90 degree angle with the body. The axillary area and the medial part of the arm are then prepared with betadine solution and draped. Using sonography (S- Nerve Ultrasound, Sonosite, Inc. WA, USA) and nerve stimulator (Plexygon, VYGON, Inc. Italy) and needle number 21 (Locoplex, VYGON, France), first four nerves of the median, ulna, radial, and musculoskeletal nerves were blocked, each with 7 cc of 1.5% lidocaine, and then the intracostobrachial nerve was blocked without ultrasound and by the conventional method, by touching the pulse of the axillary artery and injection of 2 cc of 1.5% lidocaine, on the pulse of the artery and under the skin. Intervention 3: Control group: without intercostobrachial nerve block.In this group, after IV access and monitoring of vital signs, patients undergoing sedation with Midazolam 0.15 mg/kg and fentanyl 1.5 micrograms/kg and then is placed in a supine position with his upper extrimity 90 degree angle with the body. The axillary area and the medial part of the arm are then prepared with betadine solution and draped. Using sonography (S- Nerve Ultrasound, Sonosite, Inc. WA, USA) and nerve stimulator (Plexygon, VYGON, Inc. Italy) and needle number 21 (Locoplex, VYGON, France), four nerves of the median, ulna, radial, and musculoskeletal nerves are blocked, each with 7 cc of 1.5% lidocaine. The intercostobrachial nerve block is not performed in this group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data can be shared after people have not been identified.

When:
Start of access period from 1399

To whom:
Researchers working in academic and scientific institutions

Conditions:
Academic and scientific researchers can use it for future researches.

Where to obtain:
zaman.b@iums.ac.ir

How to obtain:
Applicants should send the required request and explanation via e-mail to the registrant, which will be sent within a maximum of one month, if they meet the above requirements.

Comments:
For academic and scientific researchers, we will provide any assistance we can.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Behrooz Zaman</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hazrat-e fatemeh hospital, 21st street, Asadabadi Ave</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1433933111</zip>
        <telephone>+98 21 8871 7272</telephone>
        <email>zaman.b@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Behrooz Zaman</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hazrat-e Fatemeh Hospital, 21st Street, Asadabadi Ave.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1433933111</zip>
        <telephone>+98 21 8871 7272</telephone>
        <email>zaman.b@iums.ac.ir</email>
        <affiliation>Iran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 20 - 50
Hand and forearm soft tissue surgery with a minimum operation time of 90 minutes
ASA 1-2 Patients
BMI between 23-28
Having the right cooperation and ability to communicate with the research team</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Drug Addiction
History of seizures
Coagulation problem
Upper limb neuropathy
Vasculitis
Unstable hemodynamic
Allergy to local anesthetics</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G89.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Acute pain, not elsewhere classified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: ultrasound guided intercostobrachial nerve block group. In this group, after IV access and monitoring of vital signs, patients undergoing sedation with Midazolam 0.15 mg/kg and fentanyl 1.5 micrograms/kg and then is placed in a supine position with his upper extrimity 90 degree angle with the body.The axillary area and the medial part of the arm are then prepared with betadine solution and draped. Using sonography (S- Nerve Ultrasound, Sonosite, Inc. WA, USA) and nerve stimulator (Plexygon, VYGON, Inc. Italy) and needle number 21 (Locoplex, VYGON, France), at first four nerves of the median, ulna, radial, and musculoskeletal nerves are blocked, each with 7 cc of lidocaine 1.5 percent, and then the intercostobrachial nerve above the deep fascia are blocked with ultrasound and 2 cc of 1.5% lidocaine.</i_keyword>
      <i_keyword>Intervention group 2: intercostobrachial nerve block without ultrasound group. In this group, after IV access and monitoring of vital signs, patients undergoing sedation with Midazolam 0.15 mg/kg and fentanyl 1.5 micrograms/kg and then is placed in a supine position with his upper extrimity 90 degree angle with the body. The axillary area and the medial part of the arm are then prepared with betadine solution and draped. Using sonography (S- Nerve Ultrasound, Sonosite, Inc. WA, USA) and nerve stimulator (Plexygon, VYGON, Inc. Italy) and needle number 21 (Locoplex, VYGON, France), first four nerves of the median, ulna, radial, and musculoskeletal nerves were blocked, each with 7 cc of 1.5% lidocaine, and then the intracostobrachial nerve was blocked without ultrasound and by the conventional method, by touching the pulse of the axillary artery and injection of 2 cc of 1.5% lidocaine, on the pulse of the artery and under the skin.</i_keyword>
      <i_keyword>Control group: without intercostobrachial nerve block.In this group, after IV access and monitoring of vital signs, patients undergoing sedation with Midazolam 0.15 mg/kg and fentanyl 1.5 micrograms/kg and then is placed in a supine position with his upper extrimity 90 degree angle with the body. The axillary area and the medial part of the arm are then prepared with betadine solution and draped. Using sonography (S- Nerve Ultrasound, Sonosite, Inc. WA, USA) and nerve stimulator (Plexygon, VYGON, Inc. Italy) and needle number 21 (Locoplex, VYGON, France), four nerves of the median, ulna, radial, and musculoskeletal nerves are blocked, each with 7 cc of 1.5% lidocaine. The intercostobrachial nerve block is not performed in this group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Onset of pain of tourniquet. Timepoint: every 15 minutes. Method of measurement: Patient expression and Analogue Scale.</prim_outcome>
      <prim_outcome>Severity of tourniquet pain. Timepoint: every 15 minutes. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-04-23</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Hemmat highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
